mr grieves
New member
Nik the Trik said:mr grieves said:1. Avoid the last nightmare scenario by letting Bozak walk.
2. Play Grabbo like you pay Grabbo. Buy him out next summer if he doesn't rebound.
3. Use 1/3 to 2/3rds of Bozak's asking price to sign Boyd Gordon to play on the shutdown line.
4. Hope Kadri's game matures so he needn't play the most sheltered of minutes.
5. Play Colburne as the sheltered top-nine center.
Well, and give me some latitude on this, but isn't that needlessly risky? If we can assume that Bozak would re-sign for 4 years/20 million and either no or a limited NTC then what's the upside in letting him walk? All you're doing is losing an asset.
If, however, you keep Bozak you have an insurance policy in case Grabo doesn't rebound or Kadri can't take another step towards well-roundedness and he can be traded if the best possible scenario plays out where Grabo rebounds, Kadri steps up and Colborne looks ready. The only downside there is if somehow between now and when that all sorted itself out Bozak became untradeable but A) that's fairly unlikely and B) even if it did happen you could use a compliance buy-out on him.
Letting Bozak walk for nothing seems like a waste of an opportunity with no real gain.
I don't think Bozak would be much of an asset with a 4 year $20m contract. But he might be useful as an expensive insurance policy, you're right... Still, if the past does anything to predict the future, I'd say Grabovski returned to a scoring role wouldn't need the likes of Tyler Bozak as an insurance policy.
Here are Grabovski's 3 years leading up to his contact, and the one after:
2009/10 -- 2.1 S/GP @ 7.9% = 10G (59 GP, broke his wrist)
2010/11 -- 3.0 S/GP @ 12% = 29G (81GP) vs.
2011/12 -- 2.2 S/GP @ 14% = 23G (74GP)
2012/13 -- 1.7 S/GP @ 11.3% = 9G (48 GP, so 16G pace, if he sustains that below-average SH%)
Let's say letting Bozak go clears the way for Grabovski to return to an offensive role. If he shoots his offensive-role average of 2.4 shots/game and manages his career shooting percentage (12.4%), he's back up at 25 goals. If he's declined to, say, 11.3%, he's still well over 20. And, briefly, consider assists: 25A, 29A, 28A in each season leading up to the contract, without finishers of Kessel's calibre on his wing.
Here are Bozak's numbers for the three years leading up to his contract.
2010/11 -- 1.5 S/GP @ 12.5% = 15G (82GP)
2011/12 -- 1.5 S/GP @ 16.5% = 18G (73GP)
2012/13 -- 1.3 S/GP @ 19.7% = 12G (46GP, so 21G pace, and only if he sustains a career-high SH%).
I'm guessing, if Bozak's re-signed, he'll play where all that chemistry the team'd be paying for is (top-line scoring role). So let's say he averages his 1.4 S/GP, and shoots a full point above his career average (which is 15.5%). He'd still be under 20 goals on the season. And, cos I gave you Grabbo's, here are Bozak's assists: 17A, 29A, and 16A (in 46GP, so say 29A) the last 3 seasons.
So? as an insurance policy, Bozak for $20M looks awfully expensive? but, hey, that's the market. So, more than that, he looks like a really risky insurance policy. He'd need to not only reproduce a career year with a career-high shooting percentage but improve on it to come close to replacing what Grabovski's pretty consistently produced when in an offensive role.
So, it seems to me like a relatively healthy 30-something getting a nasty chest cold and buying some really pricey health care plan, anticipating he's got cancer? and doing so on the American individual health-care market, where that policy won't even cover the terrible thing that he probably doesn't have.